Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Cardinal Health Buys China Drug Distributor Zuellig Pharma

publication date: Nov 29, 2010
Cardinal Health made a major foray into the China pharma distribution business by paying $470 million to acquire privately held Zuellig Pharma China, a China drug distribution company with annual revenues of over $1 billion. Cardinal said that almost all of the multinational pharmas work with Zuellig in China. Zuellig China is a subsidiary of Zuellig Pharma, a Hong Kong company that distributes drugs in 17 Asian countries. Known locally as Yong Yu, Zuellig Pharma is the largest importer of drugs in China. More details....

Stock Symbol: (NYSE: CAH)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital